Marseilles, France

Francois Romagné


Average Co-Inventor Count = 9.3

ph-index = 2

Forward Citations = 50(Granted Patents)


Location History:

  • La Ciotat, FR (2012)
  • Marseilles, FR (2017)

Company Filing History:


Years Active: 2012-2017

Loading Chart...
2 patents (USPTO):

Title: The Innovations of Francois Romagné

Introduction

Francois Romagné is a notable inventor based in Marseilles, France. He has made significant contributions to the field of immunology through his innovative patents. With a total of 2 patents, Romagné's work focuses on enhancing immune responses and therapeutic applications.

Latest Patents

Romagné's latest patents include groundbreaking methods for the functionalization of immunoglobulins. The first patent, titled "Enzymatic conjugation of polypeptides," relates to methods for linking drugs to antibodies. This patent also discusses linking reagents, functionalized antibodies, pharmaceutical compositions, and methods for treating various diseases and conditions. The second patent, "Human anti-KIR antibodies," describes compositions and methods for regulating immune responses. This patent highlights human antibodies that enhance the activity of natural killer (NK) cells, thereby increasing their cytotoxicity in mammalian subjects. It also covers fragments and derivatives of these antibodies, along with their therapeutic uses.

Career Highlights

Throughout his career, Romagné has worked with esteemed institutions such as the University of Genoa and Innate Pharma S.a.s. His research has significantly advanced the understanding of immune regulation and therapeutic interventions.

Collaborations

Romagné has collaborated with notable professionals in his field, including Laurent Gauthier and Alessandro Moretta. These collaborations have further enriched his research and contributions to immunology.

Conclusion

Francois Romagné's innovative work in immunology, particularly through his patents, showcases his commitment to advancing medical science. His contributions have the potential to impact therapeutic strategies for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…